MFDS — authorised 6 May 1946
- Marketing authorisation holder: AKORN
- Status: likely_approved
🇰🇷 Bal in South Korea
MFDS authorised Bal on 6 May 1946
Marketing authorisation
Bal in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Nephrology approved in South Korea
Frequently asked questions
Is Bal approved in South Korea?
Yes. MFDS authorised it on 6 May 1946.
Who is the marketing authorisation holder for Bal in South Korea?
AKORN holds the South Korean marketing authorisation.